Cytek Biosciences, Inc. Quarterly Current Ratio in % from Q1 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Cytek Biosciences, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q3 2024.
Cytek Biosciences, Inc. Current Ratio for the quarter ending September 30, 2024 was 685 %, a 13.6% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	685	-108	-13.6%	Sep 30, 2024
Q2 2024	712	-159	-18.3%	Jun 30, 2024
Q1 2024	726	-206	-22.1%	Mar 31, 2024
Q4 2023	740	-273	-27%	Dec 31, 2023
Q3 2023	793	-307	-27.9%	Sep 30, 2023
Q2 2023	871	-311	-26.3%	Jun 30, 2023
Q1 2023	933	-206	-18.1%	Mar 31, 2023
Q4 2022	1.01K			Dec 31, 2022
Q3 2022	1.1K			Sep 30, 2022
Q2 2022	1.18K			Jun 30, 2022
Q1 2022	1.14K			Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.